2025 Presenting Companies

Loading
  1. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  2. Company Presentation
    • Regenerative Medicine
    153B
  3. Company Presentation
    • Oncology
    154
  4. Company Presentation
    • Brain Health
    153B
  5. Company Presentation
    • Oncology
    153B
  6. Company Presentation
    • Platform for Therapeutics
    154
  7. Company Presentation
    • Oncology
    153C
  8. Company Presentation
    • Oncology
    153A
  9. Company Presentation
    • Multiple Therapeutics
    153C
  10. Company Presentation
    • Oncology
    154
  11. Company Presentation
    • Dermatology
    154
  12. Company Presentation
    • Multiple Therapeutics
    153B
  13. Company Presentation
    • Brain Health
    153B
  14. Company Presentation
    • Immunology
    153A
  15. Company Presentation
    • Brain Health
    153B
  16. Company Presentation
    • Regenerative Medicine
    154
  17. Company Presentation
    • Oncology
    154
  18. Company Presentation
    • Oncology
    154
  19. Company Presentation
    • Platform for Therapeutics
    154
  20. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  21. Company Presentation
    • Immunology
    153C
  22. Company Presentation
    • Multiline Global Biopharma
    153B
  23. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  24. Company Presentation
    • Inflammation
    153A
  25. Company Presentation
    • Oncology
    154
  26. Company Presentation
    • Immunology
    153A
  27. Company Presentation
    • Orphan and Rare Disease
    153C
  28. Company Presentation
    • Tools/Drug Development Support Tech
    154
  29. Company Presentation
    • Oncology
    153A
  30. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  31. Company Presentation
    • Oncology
    154
  32. Company Presentation
    • Brain Health
    153B
  33. Company Presentation
    • Dermatology
    154
  34. Company Presentation
    • Contract Research Organization
    154
  35. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  36. Company Presentation
    • Cardiovascular
    153C
  37. Company Presentation
    • Diagnostics and Personalized Medicine
    153C
  38. Company Presentation
    • Orphan and Rare Disease
    153A
  39. Company Presentation
    • Metabolic Diseases
    153A
  40. Company Presentation
    • AI and Digital Health
    153B
  41. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  42. Company Presentation
    • Contract Manufacturing Organization
    153B
  43. Company Presentation
    • Other
    153B
  44. Company Presentation
    • Multiline Global Biopharma
    153B
  45. Company Presentation
    • Brain Health
    153A
  46. Company Presentation
    • Regenerative Medicine
    154
  47. Company Presentation
    • Platform for Therapeutics
    153A
  48. Company Presentation
    • Dermatology
    154
  49. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  50. Company Presentation
    • Other
    153C
  51. Company Presentation
    • Immunology
    153A
  52. Company Presentation
    • Inflammation
    153C
  53. Company Presentation
    • Brain Health
    153B
  54. Company Presentation
    • Immunology
    153A
  55. Company Presentation
    • Multiline Global Biopharma
    153B
  56. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  57. Company Presentation
    • Tools/Drug Development Support Tech
    154
  58. Company Presentation
    • Multiline Global Biopharma
    153B
  59. Company Presentation
    • AI and Digital Health
    153A
  60. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  61. Company Presentation
    • AI and Digital Health
    153B
  62. Company Presentation
    • Other
    153B
  63. Company Presentation
    • Oncology
    154
  64. Company Presentation
    • Regenerative Medicine
    154
  65. Company Presentation
    • Oncology
    153B
  66. Company Presentation
    • Contract Manufacturing Organization
    154
  67. Company Presentation
    • Oncology
    154
  68. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  69. Company Presentation
    • Oncology
    153B
  70. Company Presentation
    • Platform for Therapeutics
    154
  71. Company Presentation
    • Tools/Drug Development Support Tech
    154
  72. Company Presentation
    • Oncology
    153A
  73. Company Presentation
    • Reproductive/Sexual Health
    153C
  74. Company Presentation
    • Medical Devices
    154
  75. Company Presentation
    • AI and Digital Health
    153B
  76. Company Presentation
    • Tools/Drug Development Support Tech
    153C
  77. Company Presentation
    • Oncology
    153A
  78. Company Presentation
    • Respiratory
    153A
  79. Company Presentation
    • Other
    153B
  80. Company Presentation
    • Other
    153C
  81. Company Presentation
    • Multiple Therapeutics
    153B
  82. Company Presentation
    • Infectious Disease and Vaccines
    153A
  83. Company Presentation
    • Inflammation
    153A
  84. Company Presentation
    • Infectious Disease and Vaccines
    153A
  85. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  86. Company Presentation
    • Regenerative Medicine
    154
  87. Company Presentation
    • Multiple Therapeutics
    153B
  88. Company Presentation
    • Platform for Therapeutics
    154
  89. Company Presentation
    • Contract Manufacturing Organization
    154
  90. Company Presentation
    • Oncology
    154
  91. Company Presentation
    • Ophthalmology
    154
  92. Company Presentation
    • AI and Digital Health
    153C
  93. Company Presentation
    • Other
    153C
  94. Company Presentation
    • Ophthalmology
    154
  95. Company Presentation
    • Tools/Drug Development Support Tech
    154
  96. Company Presentation
    • Platform for Therapeutics
    154
  97. Company Presentation
    • Multiline Global Biopharma
    153B
  98. Company Presentation
    • Oncology
    153C
  99. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  100. Company Presentation
    • Tools/Drug Development Support Tech
    154
  101. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  102. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  103. Company Presentation
    • Oncology
    153A
  104. Company Presentation
    • Infectious Disease and Vaccines
    153B
  105. Company Presentation
    • Oncology
    153A
  106. Company Presentation
    • Oncology
    153A
  107. Company Presentation
    • Other
    154
  108. Company Presentation
    • Regenerative Medicine
    153C
  109. Company Presentation
    • Tools/Drug Development Support Tech
    154
  110. Company Presentation
    • Platform for Therapeutics
    153A
  111. Company Presentation
    • Brain Health
    153B
  112. Company Presentation
    • Platform for Therapeutics
    153C
  113. Company Presentation
    • Multiple Therapeutics
    153B
  114. Company Presentation
    • Multiple Therapeutics
    153B
  115. Company Presentation
    • Immunology
    153C
  116. Company Presentation
    • Immunology
    153A
  117. Company Presentation
    • Regenerative Medicine
    154
  118. Company Presentation
    • Platform for Therapeutics
    153C
  119. Company Presentation
    • Cardiovascular
    154
  120. Company Presentation
    • Oncology
    153B
  121. Company Presentation
    • Oncology
    154
  122. Company Presentation
    • Contract Research Organization
    153C
  123. Company Presentation
    • Platform for Therapeutics
    154
  124. Company Presentation
    • Infectious Disease and Vaccines
    153A
  125. Company Presentation
    • AI and Digital Health
    153B
  126. Company Presentation
    • Contract Research Organization
    153C
  127. Company Presentation
    • Regenerative Medicine
    154
  128. Company Presentation
    • Metabolic Diseases
    153A
  129. Company Presentation
    • Oncology
    153B
  130. Company Presentation
    • Regenerative Medicine
    153B
  131. Company Presentation
    • Respiratory
    153C
  132. Company Presentation
    • Immunology
    153C
  133. Company Presentation
    • Multiple Therapeutics
    153B
  134. Company Presentation
    • Regenerative Medicine
    153B
  135. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  136. Company Presentation
    • Oncology
    153B
  137. Company Presentation
    • Oncology
    153A
  138. Company Presentation
    • Immunology
    153C
  139. Company Presentation
    • Oncology
    153C
  140. Company Presentation
    • Oncology
    153C
  141. Company Presentation
    • Tools/Drug Development Support Tech
    154
  142. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  143. Company Presentation
    • Oncology
    153A
  144. Company Presentation
    • Platform for Therapeutics
    154
  145. Company Presentation
    • Cardiovascular
    153C
  146. Company Presentation
    • Multiple Therapeutics
    153B
  147. Company Presentation
    • Brain Health
    153B
  148. Company Presentation
    • Infectious Disease and Vaccines
    153B
  149. Company Presentation
    • Multiline Global Biopharma
    153B
  150. Company Presentation
    • Brain Health
    153A
  151. Company Presentation
    • Platform for Therapeutics
    153C
  152. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153C
  153. Company Presentation
    • Oncology
    153C
  154. Company Presentation
    • Oncology
    154
  155. Company Presentation
    • Platform for Therapeutics
    154
  156. Company Presentation
    • Oncology
    154
  157. Company Presentation
    • Ophthalmology
    154
  158. Company Presentation
    • Platform for Therapeutics
    153C
  159. Company Presentation
    • Infectious Disease and Vaccines
    153B
  160. Company Presentation
    • Infectious Disease and Vaccines
    153B
  161. Company Presentation
    • Orphan and Rare Disease
    153C
  162. Company Presentation
    • Platform for Therapeutics
    153C
  163. Company Presentation
    • Multiline Global Biopharma
    153B
  164. Company Presentation
    • Contract Manufacturing Organization
    153B
  165. Company Presentation
    • Immunology
    153A
  166. Company Presentation
    • Metabolic Diseases
    153B
  167. Company Presentation
    • Multiple Therapeutics
    153B
  168. Company Presentation
    • Tools/Drug Development Support Tech
    154
  169. Company Presentation
    • Ophthalmology
    153A
  170. Company Presentation
    • Orphan and Rare Disease
    153C
  171. Company Presentation
    • Ophthalmology
    153C
  172. Company Presentation
    • Oncology
    154
  173. Company Presentation
    • Brain Health
    153B
  174. Company Presentation
    • Immunology
    153C
  175. Company Presentation
    • Oncology
    154
  176. Company Presentation
    • Oncology
    154
  177. Company Presentation
    • Multiline Global Biopharma
    153B
  178. Company Presentation
    • Ophthalmology
    154
  179. Company Presentation
    • Multiple Therapeutics
    153B
  180. Company Presentation
    • Contract Manufacturing Organization
    153A
  181. Company Presentation
    • Orphan and Rare Disease
    153A
  182. Company Presentation
    • AI and Digital Health
    153C
  183. Company Presentation
    • Brain Health
    153B
  184. Company Presentation
    • Platform for Therapeutics
    153C
  185. Company Presentation
    • Multiple Therapeutics
    153C
  186. Company Presentation
    • Orphan and Rare Disease
    153C
  187. Company Presentation
    • Contract Manufacturing Organization
    153C
  188. Company Presentation
    • Contract Manufacturing Organization
    153A
  189. Company Presentation
    • Brain Health
    153B
  190. Company Presentation
    • Tools/Drug Development Support Tech
    154
  191. Company Presentation
    • Tools/Drug Development Support Tech
    154
  192. Company Presentation
    • Oncology
    153A
  193. Company Presentation
    • Oncology
    153C
  194. Company Presentation
    • Oncology
    154
  195. Company Presentation
    • Cardiovascular
    153C
  196. Company Presentation
    • Ophthalmology
    154
  197. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  198. Company Presentation
    • Contract Manufacturing Organization
    154
  199. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  200. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  201. Company Presentation
    • Cardiovascular
    153A
  202. Company Presentation
    • Immunology
    153C
  203. Company Presentation
    • Oncology
    153A
  204. Company Presentation
    • Multiple Therapeutics
    153B
  205. Company Presentation
    • Other
    153C
  206. Company Presentation
    • Brain Health
    153A
  207. Company Presentation
    • Oncology
    153B
  208. Company Presentation
    • Oncology
    153A
  209. Company Presentation
    • Oncology
    153A
  210. Company Presentation
    • Multiple Therapeutics
    153A
  211. Company Presentation
    • Brain Health
    153B
  212. Company Presentation
    • Oncology
    153A
  213. Company Presentation
    • Oncology
    153A
  214. Company Presentation
    • Pain Management
    153B
  215. Company Presentation
    • Metabolic Diseases
    153A
  216. Company Presentation
    • Cardiovascular
    153C
  217. Company Presentation
    • Immunology
    153C
  218. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  219. Company Presentation
    • Multiple Therapeutics
    153B
  220. Company Presentation
    • Brain Health
    153B
  221. Company Presentation
    • Respiratory
    153C
  222. Company Presentation
    • Oncology
    153A
  223. Company Presentation
    • Contract Manufacturing Organization
    154
  224. Company Presentation
    • Cell and Gene Therapy and Genome Editing
    153A
  225. Company Presentation
    • Infectious Disease and Vaccines
    153A
  226. Company Presentation
    • Other
    153B
  227. Company Presentation
    • Cardiovascular
    153C
  228. Company Presentation
    • Infectious Disease and Vaccines
    153A
  229. Company Presentation
    • Platform for Therapeutics
    153C
  230. Company Presentation
    • Brain Health
    153B
  231. Company Presentation
    • Metabolic Diseases
    153A
  232. Company Presentation
    • Oncology
    153A
  233. Company Presentation
    • Brain Health
    153B
  234. Company Presentation
    • Infectious Disease and Vaccines
    153A
  235. Company Presentation
    • Diagnostics and Personalized Medicine
    153C
  236. Company Presentation
    • Infectious Disease and Vaccines
    153B
  237. Company Presentation
    • Tools/Drug Development Support Tech
    154
  238. Company Presentation
    • Multiple Therapeutics
    153B
  239. Company Presentation
    • Brain Health
    153B
  240. Company Presentation
    • Infectious Disease and Vaccines
    153A
  241. Company Presentation
    • Pain Management
    153B
  242. Company Presentation
    • Oncology
    153C

Thank you to our Company Presentation Sponsors

johnson&johnsonpharmalogic

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading